HTA130 Value Contribution of Olipudase Alfa Therapy for the Treatment of Non-Central Nervous System Manifestations of Acid Sphingomyelinase Deficiency (ASMD) by Multi-Criteria Decision Analysis (MCDA)
- Resource Type
- Abstract
- Source
- In
Value in Health December 2022 25(12) Supplement:S321-S322 - Subject
- Language
- ISSN
- 1098-3015